Related Experiment Video
Updated: Aug 9, 2025

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Parent Views on Telemedicine in Pediatric Rheumatology: A Survey Study
Gülşah Kavrul Kayaalp1, Özlem Akgün1, Fatma Gül Demirkan1
1Department of Pediatric Rheumatology, Istanbul University Faculty of Medicine, Istanbul, Turkey.
Insights
Parents of children with rheumatic diseases show high demand for telemedicine, preferring it for continuity of care. Factors like higher education and missed appointments influence this preference.
Area of Science:
- Pediatric Rheumatology
- Digital Health
- Chronic Disease Management
Background:
- The COVID-19 pandemic accelerated telemedicine adoption for chronic disease follow-ups.
- Pediatric rheumatic diseases require consistent monitoring and management.
- Patients and caregivers seek convenient healthcare solutions.
Purpose of the Study:
- To assess parental demand for telemedicine in pediatric rheumatology.
- To understand parental opinions regarding telemedicine for their children.
- To identify factors influencing telemedicine preference among parents.
Main Methods:
- A single-center, cross-sectional, web-based survey was conducted.
- Data collected included sociodemographics, disease characteristics, clinic access, internet use, and telemedicine views.
- Multivariate analysis examined factors affecting telemedicine preference.
Main Results:
- 245 parents completed the survey, with common diagnoses including recurrent fever syndromes and juvenile idiopathic arthritis.
- Most patients used public transport (77.6%), and 27.8% missed at least one appointment.
- 70.2% of parents preferred telemedicine visits; higher education, missed appointments, and long travel times (over 1 hour) were significant factors.
Conclusions:
- Telemedicine is a desired alternative for ensuring continuity of care in pediatric rheumatology.
- Individualized patient selection is crucial for successful telemedicine implementation.
- Telemedicine can address challenges related to clinic access and appointment adherence.
Abstract:
The rapid expansion in the use of telemedicine after the COVID-19 pandemic has led many patients with chronic diseases to seek alternative ways for follow-ups. This study aimed to investigate the demands and opinions of parents of children with rheumatic diseases toward telemedicine and to examine the factors affecting telemedicine preference. A single-center, cross-sectional, Web-based survey study was conducted. Sociodemographic data, characteristics of the disease, access to the clinic, internet use, and views on telemedicine were assessed. Factors effecting telemedicine preference were evaluated by multivariate analysis. A total of 245 parents have completed the survey. The diagnoses of patients were recurrent fever syndromes (55.1%), juvenile idiopathic arthritis (31.0%), systemic connective tissue diseases (8.2%), and vasculitis (5.7%). The majority of patients came to the clinic by public transport (n = 190, 77.6%). Sixty-eight (27.8%) patients missed at least one outpatient appointment in the last year. Majority (n = 172, 70.2%) of parents stated that they would prefer telemedicine visits if it becomes available. Multivariate analysis revealed that the most related factors to telemedicine preference were higher education level (odds ratio [OR]: 6.69, confidence interval [95% CI]: 2.21-20.25, p = 0.001), missing an appointment (OR: 3.04, 95% CI: 1.41-6.56, p = 0.004), and travel time longer than 1 h (OR: 2.13, 95% CI: 1.13-3.86, p = 0.012). Telemedicine visits are in demand in pediatric rheumatology and should be considered an alternative method to ensure continuity of patient follow-up. A personal approach should be followed when selecting patients for telemedicine.
More Related Videos
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease III: Medical Management
Patient-centered Care
Rheumatic Heart Disease IV: Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Clinical Trials: Overview

